Quick Answer
KalVista Pharmaceuticals, Inc. reported Total Assets of $250.77 million for fiscal year 2025.
KalVista Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $250.77M | +6.5% |
| 2024 | $235.40M | +28.5% |
| 2023 | $183.20M | -10.1% |
| 2022 | $203.88M | -25.0% |
| 2021 | $272.01M | +194.0% |
| 2020 | $92.53M | -21.7% |
| 2019 | $118.13M | +92.4% |
| 2018 | $61.39M | +78.7% |
| 2017 | $34.34M | +38.8% |
| 2016 | $24.75M | -56.4% |
| 2015 | $56.79M | +754.8% |
| 2014 | $6.64M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $339.93M | — | +57.7% |
| July 31, 2025 | $215.50M | +7.6% | -14.1% |
| April 30, 2025 | $250.77M | +6.5% | -9.1% |
| January 31, 2025 | $275.99M | +142.2% | -6.4% |
| December 31, 2024 | $294.82M | — | +83.3% |
| October 31, 2024 | $160.83M | +15.9% | -19.7% |
| July 31, 2024 | $200.20M | +24.9% | -15.0% |
| April 30, 2024 | $235.40M | +28.5% | +106.6% |
- KalVista Pharmaceuticals, Inc. showed an increase of +6.5% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, KalVista Pharmaceuticals, Inc.’s total assets has grown by 3674.4% (from $6.64 million to $250.77 million).
- The most recent figure is from KalVista Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 10, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: